Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO).

Levy J, Gupta V, Amirazodi E, Allen-Ayodabo C, Jivraj N, Jeong Y, Davis LE, Mahar AL, De Mestral C, Saarela O, Coburn N; PRESTO Group.

Gastric Cancer. 2019 Nov 4. doi: 10.1007/s10120-019-01015-w. [Epub ahead of print]

PMID:
31686260
2.

Scoping review protocol documenting cancer outcomes and inequalities for adults living with intellectual and/or developmental disabilities.

Stirling M, Linton J, Ouellette-Kuntz H, Shooshtari S, Hallet J, Kelly C, Dawe D, Kristjanson M, Decker K, Mahar A.

BMJ Open. 2019 Nov 3;9(11):e032772. doi: 10.1136/bmjopen-2019-032772.

3.

Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis.

Davis LE, Bogner E, Coburn NG, Hanna TP, Kurdyak P, Groome PA PhD, Mahar AL.

J Epidemiol Community Health. 2019 Oct 25. pii: jech-2019-212311. doi: 10.1136/jech-2019-212311. [Epub ahead of print] Review.

PMID:
31653661
4.

Population-based study of the prevalence and management of self-reported high pain scores in patients with non-resected pancreatic adenocarcinoma.

Tung S, Coburn NG, Davis LE, Mahar AL, Myrehaug S, Zhao H, Earle CC, Nathens A, Hallet J.

Br J Surg. 2019 Nov;106(12):1666-1675. doi: 10.1002/bjs.11330.

PMID:
31639208
5.

Symptom burden among head and neck cancer patients in the first year after diagnosis: Association with primary treatment modality.

Allen-Ayodabo CO, Eskander A, Davis LE, Zhao H, Mahar AL, Karam I, Singh S, Gupta V, Bubis LD, Moody L, Barbera L, Coburn NG.

Oral Oncol. 2019 Oct 17;99:104434. doi: 10.1016/j.oraloncology.2019.09.026. [Epub ahead of print]

PMID:
31630058
6.

Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis.

Hallet J, Davis LE, Mahar AL, Liu Y, Zuk V, Gupta V, Earle CC, Coburn NG.

Gastric Cancer. 2019 Oct 18. doi: 10.1007/s10120-019-01012-z. [Epub ahead of print]

PMID:
31628561
7.

Authors' Reply to the Response to "Patient-reported symptom severity among 22,650 cancer outpatients in the last 6 months of life".

Bubis LD, Davis LE, Coburn NG, Mahar AL.

J Pain Symptom Manage. 2019 Oct 11. pii: S0885-3924(19)30572-X. doi: 10.1016/j.jpainsymman.2019.09.023. [Epub ahead of print] No abstract available.

PMID:
31610270
8.

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.

Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, Mahar A, Myers JL, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Jo HE, Webster SE, Lin QT, Rhodes JE, Salamonsen M, Wrobel JP, Harris B, Don G, Wu PJC, Ng BJ, Oldmeadow C, Raghu G, Lau EMT; Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease alliance (COLDICE) Investigators.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30342-X. doi: 10.1016/S2213-2600(19)30342-X. [Epub ahead of print]

PMID:
31578168
9.

Comparison of Patient-Reported Outcomes in Laparoscopic and Open Right Hemicolectomy: A Retrospective Cohort Study.

Vela N, Bubis LD, Davis LE, Mahar AL, Kennedy E, Coburn NG.

Dis Colon Rectum. 2019 Sep 20. doi: 10.1097/DCR.0000000000001485. [Epub ahead of print]

PMID:
31567922
10.

Patient-reported symptoms for esophageal cancer patients undergoing curative intent treatment.

Gupta V, Allen-Ayodabo C, Davis L, Zhao H, Hallet J, Mahar AL, Ringash J, Kidane B, Darling G, Coburn NG.

Ann Thorac Surg. 2019 Sep 21. pii: S0003-4975(19)31417-1. doi: 10.1016/j.athoracsur.2019.08.030. [Epub ahead of print]

PMID:
31550465
11.

Economic Analysis of Adjuvant Chemoradiotherapy Compared with Chemotherapy in Resected Pancreas Cancer.

Vela N, Davis LE, Cheng SY, Hammad A, Liu Y, Kagedan DJ, Paszat L, Bubis LD, Earle CC, Myrehaug S, Mahar AL, Mittmann N, Coburn NG; Pancreas Cancer Population Outcomes Research Group.

Ann Surg Oncol. 2019 Sep 18. doi: 10.1245/s10434-019-07808-8. [Epub ahead of print]

PMID:
31535303
12.

Population-Level Symptom Assessment Following Pancreaticoduodenectomy for Adenocarcinoma.

Tung S, Davis LE, Hallet J, Mavros MN, Mahar AL, Bubis LD, Hammad A, Zhao H, Earle CC, Barbera L, Coburn NG; and the Pancreas Cancer Population Outcomes Research Group, Siqqidui M, Li Q, Elmi M, Shin E, Hsieh E, Goyert N.

JAMA Surg. 2019 Sep 4:e193348. doi: 10.1001/jamasurg.2019.3348. [Epub ahead of print]

PMID:
31483457
13.

Patient-reported symptom severity among 22,650 cancer outpatients in the last 6 months of life.

Bubis LD, Davis LE, Canaj H, Gupta V, Jeong Y, Barbera L, Li Q, Moody L, Karanicolas PJ, Sutradhar R, Coburn NG, Mahar AL.

J Pain Symptom Manage. 2019 Aug 17. pii: S0885-3924(19)30462-2. doi: 10.1016/j.jpainsymman.2019.08.016. [Epub ahead of print]

PMID:
31430522
14.

NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.

Vargas AC, Maclean FM, Bonar F, Mahar A, Gill AJ.

Am J Surg Pathol. 2019 Aug 12. doi: 10.1097/PAS.0000000000001346. [Epub ahead of print] No abstract available.

PMID:
31414988
15.

Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study.

Troy LK, Grainge C, Corte T, Williamson JP, Vallely MP, Cooper W, Mahar AM, Lai S, Mulyadi E, Torzillo PJ, Salamonsen M, Don G, Myers J, Raghu G, Lau EMT; COLDICE Investigator Team.

BMJ Open Respir Res. 2019 Jun 21;6(1):e000443. doi: 10.1136/bmjresp-2019-000443. eCollection 2019.

16.

Symptom trajectories and predictors of severe symptoms in pancreatic adenocarcinoma at the end-of-life: a population based analysis of 2,538 patients.

Hammad A, Davis LE, Mahar AL, Bubis LD, Zhao H, Earle CC, Barbera L, Hallet J, Coburn NG.

HPB (Oxford). 2019 Jul 9. pii: S1365-182X(19)30537-4. doi: 10.1016/j.hpb.2019.04.016. [Epub ahead of print]

PMID:
31300337
17.

Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported Outcomes.

Hallet J, Davis LE, Mahar AL, Law CHL, Isenberg-Grzeda E, Bubis LD, Singh S, Myrehaug S, Zhao H, Beyfuss K, Moody L, Coburn NG.

Oncologist. 2019 Oct;24(10):1384-1394. doi: 10.1634/theoncologist.2019-0112. Epub 2019 Jul 3.

PMID:
31270268
18.

Mammary-type myofibroblastoma in the head and neck region.

Luk PP, Junaid M, Mahar A, Clark JR, Gupta R.

Pathology. 2019 Aug;51(5):544-547. doi: 10.1016/j.pathol.2019.01.015. Epub 2019 Jun 17. No abstract available.

PMID:
31221433
19.

Circulating RNA differences between patients with stable and progressive lung function in IPF.

Clynick B, Jo HE, Corte TJ, Glaspole IN, Grainge C, Hopkins PMA, Reynolds PN, Chapman S, Walters EH, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh N, Baltic S, Ryan M, Tan D, Moodley Y.

Eur Respir J. 2019 Jul 8. pii: 1802115. doi: 10.1183/13993003.02115-2018. [Epub ahead of print] No abstract available.

PMID:
31196944
20.

Readmission rates following esophageal cancer resection are similar at regionalized and non-regionalized centers: A population-based cohort study.

Gupta V, Bubis L, Kidane B, Mahar AL, Ringash J, Sutradhar R, Darling GE, Coburn NG.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):934-942.e2. doi: 10.1016/j.jtcvs.2019.04.061. Epub 2019 May 3.

PMID:
31176552
21.

Suicide in Canadian veterans living in Ontario: a retrospective cohort study linking routinely collected data.

Mahar AL, Aiken AB, Whitehead M, Tien H, Cramm H, Fear NT, Kurdyak P.

BMJ Open. 2019 Jun 2;9(6):e027343. doi: 10.1136/bmjopen-2018-027343.

22.

Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes.

Hallet J, Davis LE, Mahar AL, Isenberg-Grzeda E, Bubis LD, Myrehaug S, Zhao H, Beyfuss K, Moody L, Law CHL, Coburn NG.

Ann Surg Oncol. 2019 Sep;26(9):2711-2721. doi: 10.1245/s10434-019-07441-5. Epub 2019 May 30.

PMID:
31147993
23.

Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis.

Mavros MN, Coburn NG, Davis LE, Mahar AL, Liu Y, Beyfuss K, Myrehaug S, Earle CC, Hallet J.

CMAJ. 2019 May 27;191(21):E574-E580. doi: 10.1503/cmaj.190211.

24.

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry.

Jo HE, Corte TJ, Glaspole I, Grainge C, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Cooper WA, Mahar AM, Ellis S, Macansh S, Goh NS.

BMC Pulm Med. 2019 May 3;19(1):84. doi: 10.1186/s12890-019-0846-2.

25.

Mono-and co-applications of Ca-bentonite with zeolite, Ca-hydroxide, and tobacco biochar affect phytoavailability and uptake of copper and lead in a gold mine-polluted soil.

Lahori AH, Zhang Z, Shaheen SM, Rinklebe J, Guo Z, Li R, Mahar A, Wang Z, Ren C, Mi S, Liu T, Jing R.

J Hazard Mater. 2019 Jul 15;374:401-411. doi: 10.1016/j.jhazmat.2019.04.057. Epub 2019 Apr 16.

PMID:
31029745
26.

A retrospective cohort study comparing non-fatal self-harm emergency department visits between Canadian veterans living in Ontario and matched civilians.

Mahar AL, Cramm H, Aiken AB, Whitehead M, Tien H, Fear NT, Kurdyak P.

Int Rev Psychiatry. 2019 Feb;31(1):25-33. doi: 10.1080/09540261.2019.1580685. Epub 2019 Apr 17.

PMID:
30994372
27.

Response.

Cramm H, Mahar A, MacLean C, Birtwhistle R.

Can Fam Physician. 2019 Apr;65(4):241-242. No abstract available.

28.

Patient-reported symptoms following mastectomy alone or lumpectomy plus radiation for early stage breast cancer: a cohort study.

Davis LE, Fulton C, Bubis LD, Sussman J, Moody L, Barbera L, Li Q, Mahar AL, Coburn NG, Holloway CMB.

Breast Cancer Res Treat. 2019 Jun;175(3):721-731. doi: 10.1007/s10549-019-05196-x. Epub 2019 Mar 16.

PMID:
30879223
29.

Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study.

Mahar AL, Davis LE, Bubis LD, Li Q, Sutradhar R, Coburn NG, Barbera L.

Curr Oncol. 2019 Feb;26(1):e8-e16. doi: 10.3747/co.26.4160. Epub 2019 Feb 1.

30.

Population-based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma.

Latchana N, Davis L, Coburn NG, Mahar A, Liu Y, Hammad A, Kagedan D, Elmi M, Siddiqui M, Earle CC, Hallet J.

BJS Open. 2018 Dec 5;3(1):85-94. doi: 10.1002/bjs5.50115. eCollection 2019 Feb.

31.

Soigner les familles de militaires canadiens.

Cramm H, Mahar A, MacLean C, Birtwhistle R.

Can Fam Physician. 2019 Jan;65(1):e1-e4. French. No abstract available.

PMID:
30674522
Free PMC Article
32.

Caring for Canadian military families.

Cramm H, Mahar A, MacLean C, Birtwhistle R.

Can Fam Physician. 2019 Jan;65(1):9-11. No abstract available. Erratum in: Can Fam Physician. 2019 Apr;65(4):242.

33.

Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Luk PP, Selinger CI, Cooper WA, Mahar A, Palme CE, O'Toole SA, Clark JR, Gupta R.

Head Neck Pathol. 2019 Sep;13(3):397-414. doi: 10.1007/s12105-018-0988-1. Epub 2018 Nov 22. Review.

PMID:
30467669
34.

Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario.

Mahar AL, El-Sedfy A, Dixon M, Siddiqui M, Elmi M, Ritter A, Vasilevska-Ristovska J, Jeong Y, Helyer L, Law C, Zagorski B, Coburn NG.

Curr Oncol. 2018 Oct;25(5):e436-e443. doi: 10.3747/co.25.3953. Epub 2018 Oct 31.

35.

Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review.

Hallet J, Pessaux P, Beyfuss KA, Jayaraman S, Serrano PE, Martel G, Coburn NG, Piardi T, Mahar AL.

Surg Endosc. 2019 Feb;33(2):366-376. doi: 10.1007/s00464-018-6479-3. Epub 2018 Oct 22. Review.

PMID:
30350105
36.

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Jo HE, Glaspole I, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Macansh S, Grainge C, Keir GJ, Hayen A, Henderson D, Klebe S, Heinze SB, Miller A, Rouse HC, Duhig E, Cooper WA, Mahar AM, Ellis S, McCormack SR, Ng B, Godbolt DB, Corte TJ.

Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17.

37.

Outcomes of Non-curative Gastrectomy for Gastric Cancer: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).

Jeong Y, Mahar AL, Coburn NG, Wallis CJ, Satkunasivam R, Beyfuss K, Karanicolas PJ, Law CHL, Hallet J.

Ann Surg Oncol. 2018 Dec;25(13):3943-3949. doi: 10.1245/s10434-018-6824-8. Epub 2018 Oct 8.

PMID:
30298321
38.

Assessing tools for management of noncolorectal nonneuroendocrine liver metastases: External validation of a prognostic model.

Tsang ME, Mahar AL, Martel G, Cleary SP, Nanji S, Ouellet JF, Hernandez-Alejandro R, Wei AC, Hallet J; Members of the Canadian Noncolorectal Nonneuroendocrine Liver Metastases Study Group.

J Surg Oncol. 2018 Nov;118(6):1006-1011. doi: 10.1002/jso.25228. Epub 2018 Sep 9.

PMID:
30196563
39.

Evaluating TNM stage prognostic ability in a population-based cohort of gastric adenocarcinoma patients in a low-incidence country.

Mahar AL, Zagorski B, Kagedan D, Dixon M, El-Sedfy A, Vasilevska-Ristovska J, Cortinovis D, Rowsell C, Law C, Helyer L, Paszat L, Coburn N.

Can J Public Health. 2018 Aug;109(4):480-488. doi: 10.17269/s41997-018-0102-1. Epub 2018 Aug 8.

PMID:
30091108
40.

Patient-reported symptoms after breast cancer diagnosis and treatment: A retrospective cohort study.

Davis LE, Bubis LD, Mahar AL, Li Q, Sussman J, Moody L, Barbera L, Holloway CM, Coburn NG.

Eur J Cancer. 2018 Sep;101:1-11. doi: 10.1016/j.ejca.2018.06.006. Epub 2018 Jul 13.

PMID:
30014970
41.

Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review.

Gupta V, Coburn N, Kidane B, Hess KR, Compton C, Ringash J, Darling G, Mahar AL.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):847-856. doi: 10.1016/j.jtcvs.2018.03.146. Epub 2018 Apr 12.

PMID:
30011772
42.

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.

Ahmadzada T, Kao S, Reid G, Boyer M, Mahar A, Cooper WA.

J Clin Med. 2018 Jun 15;7(6). pii: E153. doi: 10.3390/jcm7060153. Review.

43.

Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.

Luk PP, Selinger CI, Mahar A, Cooper WA.

Arch Pathol Lab Med. 2018 Aug;142(8):922-928. doi: 10.5858/arpa.2017-0502-RA. Epub 2018 Jun 14. Review.

PMID:
29902067
44.

FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center.

Vargas AC, Selinger C, Satgunaseelan L, Cooper WA, Gupta R, Stalley P, Brown W, Soper J, Schatz J, Boyle R, Thomas DM, Tattersall MHN, Bhadri V, Maclean F, Bonar SF, Scolyer RA, Karim RZ, McCarthy SW, Mahar A, O'Toole SA.

Asia Pac J Clin Oncol. 2019 Feb;15(1):38-47. doi: 10.1111/ajco.12980. Epub 2018 May 28.

PMID:
29806089
45.

Fluorescent In Situ Hybridization in Surgical Pathology Practice.

Gupta R, Cooper WA, Selinger C, Mahar A, Anderson L, Buckland ME, O'Toole SA.

Adv Anat Pathol. 2018 Jul;25(4):223-237. doi: 10.1097/PAP.0000000000000194. Review.

PMID:
29727321
46.

Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data.

Mahar AL, Jeong Y, Zagorski B, Coburn N.

BMC Health Serv Res. 2018 May 2;18(1):309. doi: 10.1186/s12913-018-3125-7.

47.

Impact of paternal deployment to the conflicts in Iraq and Afghanistan and paternal post-traumatic stress disorder on the children of military fathers.

Fear NT, Reed RV, Rowe S, Burdett H, Pernet D, Mahar A, Iversen AC, Ramchandani P, Stein A, Wessely S.

Br J Psychiatry. 2018 Jun;212(6):347-355. doi: 10.1192/bjp.2017.16. Epub 2018 Apr 18.

48.

The impact of perioperative blood transfusions on short-term outcomes following hepatectomy.

Hallet J, Mahar AL, Nathens AB, Tsang ME, Beyfuss KA, Lin Y, Coburn NG, Karanicolas PJ.

Hepatobiliary Surg Nutr. 2018 Feb;7(1):1-10. doi: 10.21037/hbsn.2017.05.07.

49.

Symptom Burden in the First Year After Cancer Diagnosis: An Analysis of Patient-Reported Outcomes.

Bubis LD, Davis L, Mahar A, Barbera L, Li Q, Moody L, Karanicolas P, Sutradhar R, Coburn NG.

J Clin Oncol. 2018 Apr 10;36(11):1103-1111. doi: 10.1200/JCO.2017.76.0876. Epub 2018 Mar 1.

PMID:
29494259
50.

Pigmented Paget's disease of the nipple mistaken for melanoma in situ: a diagnostic pitfall for the unwary.

Solinas A, Mahar A, Cooper WA, Thompson JF, Spillane AJ, Scolyer RA.

Pathology. 2018 Apr;50(3):364-367. doi: 10.1016/j.pathol.2017.09.018. Epub 2018 Mar 1. No abstract available.

PMID:
29490872

Supplemental Content

Support Center